Ondine Biomedical Incorporated operates in the Pharmaceutical preparations sector. Ondine Biomedical Inc., formerly Ondine Biopharma Corporation, is a medical device company developing photodisinfection based products. The Company is developing non-antibiotic therapies for the treatment of a spectrum of bacterial, fungal and viral infections. The Company focuses on developing products utilizing its light-activated technology, primarily for the hospital acquired infection market. Periowave is a commercial product developed by the Company utilizing its PDD platform technology. It is a non-invasive approach to the treatment of periodontal disease in adults. It focuses on MRSAid and the photodynamic endotracheal tube treatment (PETT) System to prevent Ventilator-associated pneumonia designed for the hospital acquired infection market. On December 7, 2009, it acquired Advanced Photodynamic Technologies, Inc. In September 2010, the Company completed the sale of a majority interest in Sinuwave Technologies Corporation. In our complete report available for purchase the company is compared to: Alda Pharmaceuticals Corp., BELLUS Health Incorporation and Sembiosys Genetics Inc.